News

Aduhelm™ (aducanumab) is a drug made by Biogen to treat Alzheimer’s disease. When the US Food and Drug Administration (FDA) first approved Aduhelm, it was exciting news. Aduhelm was the...

Editor's note: the Aduhelm (aducanumab) drug recommendations have changed since its original FDA approval in June 2021. You can see all updates regarding Biogen's Aduhelm here. Just weeks after it...

As the coronavirus and flu season collide, this upcoming fall and winter will be like none the world has ever seen. Here in the United States, it is important to...

Even after months of navigating life in the COVID-19 era, keeping up with new information and news can be overwhelming. Below are some of the latest developments surrounding COVID-19 for...

Many of us are overwhelmed by the amount of information available on COVID-19. Keeping up with all of the news can be challenging. Here are some of the top developments...

The 2020 Fatigue and Health survey has now closed. Thank you for your interest! We are excited to share the results with you soon.Exhaustion, tiredness, weariness... fatigue. We know chronic...

On March 19, the U.S. Food and Drug Administration (FDA) approved the testing of two drugs, chloroquine (hydroxychloroquine) and remdesivir, to treat people with COVID-19. The drugs have been given...

With all of the news circulating about the novel (new) coronavirus, it can be easy to feel overwhelmed or anxious. This is especially true if you are immune-compromised due to...

For those living with chronic health conditions, current news about the coronavirus (COVID-19) can be anxiety-inducing. We have questions and concerns about how the virus is transmitted, how it can...